Skip to Main Content
Back to News

VOYAGER THERAPEUTICS Earnings Preview: Recent $VYGR Insider Trading, Hedge Fund Activity, and More

None

VOYAGER THERAPEUTICS ($VYGR) is expected to release its quarterly earnings data on Tuesday, March 11th after market close, per Finnhub. Analysts are expecting revenue of $16,908,621 and earnings of -$0.37 per share.

You can see Quiver Quantitative's $VYGR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

VOYAGER THERAPEUTICS Insider Trading Activity

VOYAGER THERAPEUTICS insiders have traded $VYGR stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $VYGR stock by insiders over the last 6 months:

  • ALFRED SANDROCK (President and CEO) has made 0 purchases and 2 sales selling 28,346 shares for an estimated $123,682.
  • ROBIN SWARTZ (COO & CBO) has made 0 purchases and 4 sales selling 20,431 shares for an estimated $99,914.
  • SANDELL JACQUELYN FAHEY (Chief Legal Officer) has made 0 purchases and 2 sales selling 10,357 shares for an estimated $54,307.
  • TODD ALFRED CARTER (Chief Scientific Officer) has made 0 purchases and 3 sales selling 9,909 shares for an estimated $44,276.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

VOYAGER THERAPEUTICS Hedge Fund Activity

We have seen 63 institutional investors add shares of VOYAGER THERAPEUTICS stock to their portfolio, and 71 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles